The impact of the coronavirus outbreak on the M&A Deal Activity

Impact of the virus on the number and conclusion of M&A dealsSince the novel coronavirus (COVID-19) pandemic keeps up its omnipresence in the global news, the M&A market is now plummeting after several years of booming M&A activity. Indeed, this unprecedented crisis caused severe ravages in the stock market and hence drastically impacted corporate shareContinue reading “The impact of the coronavirus outbreak on the M&A Deal Activity”

The birth of a true Apple Watch competitor

Google has struck a $2.1bn deal to buy fitness-tracking pioneer Fitbit, in order to team up to take on Apple’s fast-growing wearable-tech business. Google announced the acquisition in November 2019, and the deal is expected to go through in early 2020 following the Fitbit shareholders’ approval of the third of January. Could this mean we’llContinue reading “The birth of a true Apple Watch competitor”

LVMH’s breakfast at Tiffany’s with the bill of $16.2 billion

LVMH Group will acquire Tiffany & Co, an American jeweler known for engagement rings and white diamond necklaces, for $ 16.2 billion with $135 per share, the biggest deal in luxury industry.  About the Buyer: LVMH Moët Hennessy Louis Vuitton The buyer of this deal is LVMH Moët Hennessy Louis Vuitton, the world’s leading high-qualityContinue reading “LVMH’s breakfast at Tiffany’s with the bill of $16.2 billion”

Coca-Cola takes plunge into coffee with 3.9 billion-pound Costa deal

On the 31st of August 2018, Coca-Cola (NYSE:KO) announced that it had reached a definitive agreement to acquire the U.K. Coffee-shop leader Costa for 3.9 billion pounds ($5.1 billion). This brave acquisition is a turning point for both companies.             The Coca-Cola Company  The buyer is The Coca-Cola Company, one of the biggest beverage companyContinue reading “Coca-Cola takes plunge into coffee with 3.9 billion-pound Costa deal”

Giant deal in the pharmaceutical sector: Bristol-Myers Squibb buys Celgene

Last 6th January, US drug manufacturer Bristol-Myers Squibb (NYSE:BMY) and Celgene Corporation (NASDAQ:CELG) announced that they have entered into a definitive merger agreement under which BMY would have acquired Celgene for an equity value of approximately USD 74bn. The board of the two firms welcome the acquisition which will imply that Bristol-Myers Squibb’s shareholders willContinue reading “Giant deal in the pharmaceutical sector: Bristol-Myers Squibb buys Celgene”

Small investment bank boutiques cash in on mega M&A deals

(On the right side is Simon Warshaw and on the left side is Michael Zaoui)   While it’s normal that big name players take mega deals in M&A market, small investment bank boutiques in London have shared a bigger slice of the pie than ever before, and, many times, some of them are beating bigContinue reading “Small investment bank boutiques cash in on mega M&A deals”

Consolidation in the luxury industry: acquisition of Versace by Michael Kors

Authors: Alessandro Babbaro, Riccardo Lizzi Michael Kors Holdings Limited announced the acquisition of Versace for $2.12bn, on September 25th. Upon completion of the deal, which is expected to be during Q4 2019, the group will rebrand as Capri Holdings with combined annual revenues of $6bn. This deal follows the £896m acquisition of Jimmy Choo, datedContinue reading “Consolidation in the luxury industry: acquisition of Versace by Michael Kors”

Bidding War fires up the largest European deal of 2017

On May 15th, 2017 Atlantia has announced its intention to acquire its Spanish competitor, Abertis. Atlantia, Italian toll operator whose main asset is Autostrade per l’Italia, the largest concessionaire on the Italian highway network, is a holding company belonging to the Benetton family. Under the management of its CEO, Giovanni Castellucci, former partner at theContinue reading “Bidding War fires up the largest European deal of 2017”

Johnson & Johnson to Acquire Actelion for $30 Billion With Spin-Out of New R&D Company

Johnson & Johnson (NYSE:JNJ), the world’s largest healthcare holding company, with total registered worldwide sales of $71.89bn in 2016, has unveiled its intention to acquire the Swiss drug-maker Actelion Ltd (SIX:ATLN) with a move that will cost $30bn to the US company. Johnson & Johnson Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packagedContinue reading “Johnson & Johnson to Acquire Actelion for $30 Billion With Spin-Out of New R&D Company”